Medical Weight Loss vs. DIY Diets: What the Data Really Shows

DIY diets, Medical Weight Loss, Ozempic, physician-led weight loss, semaglutide, set point weight, tirzepatide, Wegovy, weight cycling risks, Zeam Health and Wellness

Most people do not start a new diet with the assumption they will fail. At the start, there is usually a level of hope, maybe even excitement. You find a plan that feels attainable, you commit, and you start with enthusiasm. The pounds drop, you feel good, and for a moment, it seems that this […]

Why More Women Are Choosing Semaglutide Over Crash Diets

GLP-1 weight loss, Medical Weight Loss, ozempic Folsom, Ozempic weight loss, semaglutide Roseville, semaglutide weight loss, supervised weight loss programs, sustainable weight loss, Wegovy, women and semaglutide

Most women know the routine. You start a crash diet, cut nearly everything you enjoy, drop a few pounds fast, and then the weight comes back, sometimes more than before. It is discouraging and exhausting. Diet culture has pushed this cycle for decades, and it leaves people feeling stuck. Now there is a turn happening. […]

Semaglutide vs. Ozempic: Which Weight Loss Option Is Right for You?

GLP-1 Medications, GLP-1 therapy, hormone weight loss, Medical Weight Loss, Ozempic, ozempic Folsom, semaglutide, semaglutide Roseville, semaglutide vs ozempic, Wegovy, weight loss injections, weight loss plateau

Over the past few years, GLP-1 medications have moved from niche prescriptions to everyday conversation. People who once cycled through diets and gym plans without lasting results are now looking at medical options that work with the body’s own appetite signals. Among these, semaglutide and Ozempic are the names you hear most often. The two […]

Appointment Request Form










    Note: We are not currently accepting Medi-Cal Insurance at this time.






    PLEASE NOTE: This is an appointment request only. The office will reach out to you to confirm the appointment date and time. If this is an emergency, please call the office.